Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3484 USD | +1.58% | +2.59% | +107.38% |
Apr. 02 | Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024 | |
Apr. 01 | BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 32
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Odor-No-More Environmental
93.5
%
| 4 | 74.3 % | 11 | 93.5 % | +161.55% |
BioLargo Engineering, Science & Technologies
19.6
%
| 2 | 33.0 % | 2 | 19.6 % | +23.37% |
Intersegment
-13.5
%
| 0 | -8.4 % | -2 | -13.5 % | +234.75% |
BioLargo Canada
0.2
%
| 0 | 0.0 % | 0 | 0.2 % | +2,900.00% |
Clyra Medical
0.2
%
| 0 | 1.0 % | 0 | 0.2 % | -64.29% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 6 | 100.0 % | 12 | 100.0 % | +107.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Director of Finance/CFO | 68 | 08-01-31 | |
Chief Operating Officer | 55 | 02-05-31 | |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 07-03-31 |
Mitch Noto
PRN | Corporate Officer/Principal | - | - |
Tonya Chandler
SAM | Sales & Marketing | - | - |
A. J. Sexton
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Marshall
BRD | Director/Board Member | 81 | 06-04-27 |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 07-03-31 |
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Chief Operating Officer | 55 | 02-05-31 | |
Jack Strommen
BRD | Director/Board Member | 54 | 17-05-31 |
Linda Park
BRD | Director/Board Member | 46 | 22-10-31 |
Christina Bray
BRD | Director/Board Member | - | 22-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 295,552,937 | 253,423,688 ( 85.75 %) | 0 | 85.75 % |
Company contact information
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+107.38% | 102M | |
+5.14% | 103B | |
-5.63% | 63.04B | |
+39.52% | 39.49B | |
+12.91% | 36.62B | |
+7.18% | 32.44B | |
+7.32% | 19.07B | |
+12.86% | 16.63B | |
+16.93% | 15.14B | |
+5.60% | 14.73B |
- Stock Market
- Equities
- BLGO Stock
- Company BioLargo, Inc.